The CMT Research Foundation is pleased to welcome Peter J. deSilva as the newest member of its board of directors. With more than 30 years of experience as a results-oriented leader in the financial sector, Mr. deSilva will bring his world-class expertise in strategic development and financial management to help the CMT Research Foundation raise significant funds for cutting-edge research and scientific innovation.

Mr. deSilva is a fellow at Harvard University in the institution’s Advanced Leadership Initiative. Most recently, he spent the past three years as the retail president for TD Ameritrade, where he was responsible for all facets of the $5 billion+ retail business segment, including strategy formulation, financial performance, sales, digital strategy, distribution, client experience, associate experience for 5,000 employees and compliance and risk management. He has also served as president of Scottrade Financial Services and UMB Financial Corporation as well as a senior leader at Fidelity Investments.

CMT Research Foundation Board Member Peter deSilva

“As someone with Charcot-Marie-Tooth who understands the immense physical and mental toll it takes on families like mine, it’s my personal mission to ensure no one has to experience CMT or live in fear of what the future may bring because there are no treatments or cures for the disease. I look forward to helping raise significant capital to invest in the most promising science and research innovations to deliver individuals and families like mine a much-needed cure.”

— Peter J. deSilva

In addition to the CMT Research Foundation board, Mr. deSilva currently serves on the boards of Fidelity Security Life Insurance Company, the Robert W. Plaster Trusts and Charitable Foundation, MRI Global, and the National World War I Museum and Memorial. He has a bachelor’s degree in management from the University of Massachusetts, Dartmouth. He holds his FINRA Series 24 (General Securities Principal), Series 7 (General Securities Representative), Series 65 (Uniform Investment Advisor), Series 63 (Uniform Securities Agent State Law Examination), and Series 6 (Investment Company and Contracts Products Representative) licenses.

Outside of the office, Mr. deSilva is passionate about history, boating, cycling, diving — and of course, volunteering for causes that are important to him and his family. You can connect with Peter deSilva on LinkedIn and Twitter.


Meet the CMT Research Foundation Board

The CMT Research Foundation’s board of directors consists of leading experts worldwide who selflessly dedicate their time and talents to deliver treatments and cures for CMT during our lifetime. Get to know these passionate volunteer leaders.